32 results on '"Magalhães, Pedro V. S."'
Search Results
2. Characteristics of suicides of young people in Porto Alegre, Southern Brazil, from 2010 to 2016
- Author
-
Crespo, Kleber Cardoso, Rios, Angelita Maria Ferreira Machado, Martini, Murilo, Barcellos, Camila, De Borba Telles, Lisieux Elaine, and Magalhães, Pedro V. S.
- Published
- 2021
- Full Text
- View/download PDF
3. A Qualitative Study on Traumatic Experiences of Suicide Survivors.
- Author
-
Contessa, Júlia Camargo, Padoan, Carolina Stopinski, Silva, Jéssica Leandra Gonçalves da, and Magalhães, Pedro V. S.
- Subjects
SUICIDE ,GRIEF ,INTERVIEWING ,QUALITATIVE research ,RESEARCH funding ,WOUNDS & injuries - Abstract
The suicide of a loved one can be a traumatic experience. The objective of this study was to investigate trauma-related experiences of suicide survivors. This is a qualitative study with people who had recently lost a family member or a close one to suicide, conducted at least two months after the event. Forty-one participants agreed to take part in the study and were interviewed. The interviewees' perception was that suicide brought harm, symptoms, and suffering. Traumatic experiences can begin immediately after the event, with many reporting symptoms lasting many months and persistent impact, both personal and to the family. Postvention models after suicide should incorporate such findings, and investigate trauma consistently. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
4. “Why throw away something useful?”: Attitudes and opinions of people treated for bipolar disorder and their relatives on organ and tissue donation
- Author
-
Padoan, Carolina S., Garcia, Lucas F., Rodrigues, Aline A., Patusco, Lucas M., Atz, Mariana V., Kapczinski, Flavio, Goldim, José R., and Magalhães, Pedro V. S.
- Published
- 2017
- Full Text
- View/download PDF
5. Gender-related and non-gender-related female homicide in Porto Alegre, Brazil, from 2010 to 2016.
- Author
-
Rios, Angelita Maria Ferreira Machado, Crespo, Kleber Cardoso, Martini, Murilo, Telles, Lisieux Elaine De Borba, and Magalhães, Pedro V. S.
- Subjects
HOMICIDE ,DRUG traffic ,TRAFFIC violations ,HOMICIDE rates ,URBAN violence ,AUTOPSY - Abstract
Female homicide is a global phenomenon with a higher prevalence in countries in Asia, Africa, and the Americas. Life expectancy in Brazil is compromised by the high risk of death from male and female homicides, a growing social problem. This study aimed to integrate different public datasets and describe the sociodemographic, criminal, and medicolegal characteristics of the homicides of girls and women occurring in Porto Alegre, southern Brazil, from 2010 to 2016. The data were obtained from autopsy reports, police reports, and records from crime scenes. During this period, there was a significant increase in overall standardized rates of female homicides (4.98 to 10.85), with a pronounced increase in non-gender-related deaths, especially due to urban violence, such as involvement in drug trafficking and other crimes and robbery resulting in death. Young (15–29 years of age), non-White women were the most affected. Increased female homicide rates due to non-gender-related factors is a new and worrying phenomenon in Brazil. Obtaining specific data on the profile of victims and characteristics of violence is a crucial step in facing the problem and directing public policies. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. Moderating effects of diagnosis and gender on the influence of age on electroconvulsive therapy outcome.
- Author
-
Tedeschi, Eduardo, Hoffmann, Mauricio S., and Magalhães, Pedro V. S.
- Subjects
ELECTROCONVULSIVE therapy ,DIAGNOSIS ,GENDER - Abstract
The article discusses the moderating effects of diagnosis and gender on the influence of age on the outcome of electroconvulsive therapy (ECT). The study included adult inpatients who underwent ECT for acute mental illness and analyzed the relationship between age, diagnosis, gender, and remission. The results showed that age alone was not a significant predictor of remission, but when diagnosis and gender were taken into account, older age predicted a higher likelihood of nonremission. The study suggests that diagnosis and gender may be important factors to consider when examining the relationship between age and ECT outcomes. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
7. Violent and sexual behaviors and lifetime use of crack cocaine: a population-based study in Brazil
- Author
-
Narvaez, Joana C. M., Jansen, Karen, Pinheiro, Ricardo T., Kapczinski, Flávio, Silva, Ricardo A., Pechansky, Flávio, and Magalhães, Pedro V. S.
- Published
- 2014
- Full Text
- View/download PDF
8. Socioeconomic and substance use changes in emerging adults and their relationship with mood disorders in a population-based cohort.
- Author
-
de Azambuja Farias, Clarisse, de Azevedo Cardoso, Taiane, da Silva, Marielle Moro, D'Angelo, Francesca, Mondin, Thaise Campos, de Mattos Souza, Luciano Dias, da Silva, Ricardo Azevedo, Kapczinski, Flavio, Jansen, Karen, and Magalhães, Pedro V. S.
- Subjects
AFFECTIVE disorders ,YOUNG adults ,SUBSTANCE abuse ,MENTAL depression ,SUBSTANCE abuse risk factors - Abstract
In this report, we aim to assess the interaction of bipolar disorder and major depressive disorder with the evolution of social roles, economic classification, and substance misuse in emerging adults. This is a longitudinal populationbased study (n = 231 at baseline), in which participants were reassessed at a mean of 5 years after baseline. A structured clinical interview was used to diagnose the participants with bipolar disorder and major depression; a control group without mood disorders was included. Men with mood disorders were less likely to be married in the beginning of the study and less likely to work in the follow-up. Women with major depression were less likely to study and more likely to be in a lower economic class at the beginning of the study. In comparison, women with bipolar disorder were less likely to live with their parents and more likely to live with their children in the first wave of the study. Substance misuse was more likely in people with mood disorders, especially in men, and women with bipolar disorder had the highest likelihood in the follow-up. Albeit longitudinal analyses were limited by a possibly insufficient sample size and mediating mechanisms for change, such as stigma, were not explored, the study suggests sex-related specificities regarding the change in social roles and substance use in people with mood disorders. Emerging adults, especially those with mood disorders, are in a period of change and instability and at a greater risk for substance use and abuse. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
9. Circadian preference in bipolar disorder
- Author
-
Giglio, Larriany Maria Falsin, Magalhães, Pedro V. S., Andersen, Mônica Levy, Walz, Julio Cesar, Jakobson, Lourenço, and Kapczinski, Flávio
- Published
- 2010
- Full Text
- View/download PDF
10. Neuroimaging and illness progression
- Author
-
Frey, Benicio N., Minuzzi, L, Haarman, Bartholomeus, Sassi, R, Kapczinski, Flávio, Vieta, Eduard, Magalhães, Pedro V. S., Berk, Michael, and Clinical Cognitive Neuropsychiatry Research Program (CCNP)
- Subjects
nervous system - Abstract
•Asymptomatic children at high-risk to develop BD have shown gray matter volume changes in several prefrontal cortical areas and reduced frontal and increased amygdala activation; Preliminary evidence suggests that development of BD may be associated with lower amygdala volumes •Initial studies pointed to increased size of brain ventricles in patients with multiple episodes of BD •PFC seems to be the area where reductions in grey matter are more pronounced in BD. •Several studies replicated an increased number of WMH among adults BD patients; WMH might be a potential marker of late stages in bipolar disorder •Functional neuroimaging studies in BD patients have shown abnormal activation involving fronto-limbic circuitry; however the usefulness of fMRI in staging/illness progression is still unknown •Positron emission tomography molecular imaging demonstrated an increase in activated microglia in BD, supporting the theory that microglia activation plays an important role in the pathophysiology of BD.
- Published
- 2015
11. Barriers and facilitators perceived by people with bipolar disorder for the practice of exercise: a qualitative study.
- Author
-
Pereira, Caroline Silveira, Padoan, Carolina Stopinski, Garcia, Lucas França, Patusco, Lucas, and Magalhães, Pedro V. S.
- Subjects
BIPOLAR disorder ,EXERCISE ,QUALITATIVE research ,GROUNDED theory ,SEMI-structured interviews - Abstract
Copyright of Trends in Psychiatry & Psychotherapy is the property of Associacao de Psiquiatria do Rio Grande do Sul and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2019
- Full Text
- View/download PDF
12. Post-traumatic stress disorder and interleukin 6 – Authors' reply
- Author
-
Passos, Ives Cavalcante, Vasconcelos-Moreno, Mirela Paiva, Costa, Leonardo Gazzi, Kunz, Maurício, Brietzke, Elisa, Quevedo, Joao, Salum, Giovanni, Magalhães, Pedro V S, Kapczinski, Flávio, and Kauer-Sant'Anna, Márcia
- Published
- 2016
- Full Text
- View/download PDF
13. Relative impact of diagnosis and clinical stage on response to electroconvulsive therapy: a retrospective cohort.
- Author
-
Tedeschi, Eduardo, Hoffmann, Mauricio S., and Magalhães, Pedro V. S.
- Subjects
- *
ELECTROCONVULSIVE therapy , *MENTAL illness , *DIAGNOSIS , *REGRESSION analysis , *MANIA , *PSYCHOSES - Abstract
Objectives: Electroconvulsive therapy (ECT) is commonly indicated for refractory psychiatric disorders. However, little research has compared response across diagnoses. Here, we aimed to evaluate the relative impact of diagnosis and clinical staging as response predictors in a crossdiagnostic sample. Methods: In a retrospective cohort of adult inpatients (n=287) who underwent at least six sessions of ECT, we investigated predictors of complete response (a clinical global impression of 1) to ECT. We use adjusted regression models to estimate the impact of clinical diagnosis and staging on complete response and dominance analysis to assess the relative importance of these predictors. Results: Those for whom a depressive episode was a primary indication for treatment were the most likely to have complete improvement, while those with psychosis were the least likely; clinical stage had a significant influence on outcome in all diagnoses. A diagnosis of psychosis was the strongest predictor of non-response. Conclusions: A diagnosis of psychosis (mainly schizophrenia) was the strongest predictor of nonresponse. We also found that clinical staging can aggregate information on ECT response that is independent of clinical diagnosis. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
14. Do Comorbid Anxiety Disorders Moderate the Effects of Psychotherapy for Bipolar Disorder? Results From STEP-BD.
- Author
-
Deckersbach, Thilo, Peters, Amy T., Sylvia, Louisa, Urdahl, Anna, Magalhães, Pedro V. S., Otto, Michael W., Frank, Ellen, Miklowitz, David J., Berk, Michael, Kinrys, Gustavo, and Nierenberg, Andrew
- Subjects
ANXIETY disorders ,BIPOLAR disorder ,COMORBIDITY ,PSYCHOTHERAPY ,HEALTH outcome assessment ,DRUG therapy ,MENTAL depression - Abstract
Objective: At least 50% of individuals with bipolar disorder have a lifetime anxiety disorder. Individuals with both bipolar disorder and a co-occurring anxiety disorder experience longer illness duration, greater illness severity, and poorer treatment response. The study explored whether comorbid lifetime anxiety in bipolar patients moderates psychotherapy treatment outcome. Method: In the Systematic Treatment Enhancement Program randomized controlled trial of psychotherapy for bipolar depression, participants received up to 30 sessions of intensive psychotherapy (family-focused therapy, interpersonal and social rhythm therapy, or cognitive-behavioral therapy) or collaborative care, a three- session comparison treatment, plus pharmacotherapy. Using the number needed to treat, we computed effect sizes to analyze the relationship between lifetime anxiety disorders and rates of recovery across treatment groups after 1 year. Results: A total of 269 patients (113 women) with a comorbid lifetime anxiety disorder (N=177) or without a comorbid lifetime anxiety disorder (N=92) were included in the analysis. Participants with a lifetime anxiety disorder were more likely to recover with psychotherapy than with collaborative care (66% compared with 49% recovered over 1 year; number needed to treat5.88, small to medium effect). For patients without a lifetime anxiety disorder, there was no difference between rates of recovery in psychotherapy compared with collaborative care (64% compared with 62% recovered; number needed to treat=50, small effect). Participants with one lifetime anxiety disorder were likely to benefit from intensive psychotherapy compared with collaborative care (84% compared with 53% recovered; number needed to treat=3.22, medium to large effect), whereas patients with multiple anxiety disorders exhibited no difference in response to the two treatments (54% compared with 46% recovered; number needed to treat=12.5, small effect). Conclusions: Depressed patients with bipolar disorder and comorbid anxiety may be in particular need of additional psychotherapy for treating acute depression. These results need to be replicated in studies that stratify bipolar patients to treatments based on their anxiety comorbidity status. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
15. Peripheral oxidative damage in early-stage mood disorders: a nested population-based case-control study.
- Author
-
Magalhães, Pedro V. S., Jansen, Karen, Pinheiro, Ricardo Tavares, Colpo, Gabriela Delevati, da Motta, Leonardo Lisbôa, Klamt, Fábio, da Silva, Ricardo Azevedo, and Kapczinski, Flávio
- Subjects
AFFECTIVE disorders ,CASE-control method ,COHORT analysis ,PATHOLOGICAL physiology ,BIPOLAR disorder ,MENTAL depression ,OXIDATIVE stress ,PATHOLOGICAL psychology - Abstract
Systemic toxicity is a relevant dimension of pathophysiology in bipolar disorder, and oxidative damage is one potential link between central and peripheral pathology. Although there is mounting evidence that chronic bipolar disorder is associated with oxidative stress, studies in the early stages of bipolar disorder are scarce, and heavily reliant on clinical in lieu of population studies. The objective of this study was to confirm leading hypotheses about the role of oxidative damage in bipolar disorder. To that end, we nested a case-control study in a population-based study of young adults aged 18–24 yr. After an initial psychopathology screen, all people with a lifetime history of (hypo)mania and matched controls underwent a structured diagnostic interview. This yielded a sample of 231 participants, in whom we measured serum protein carbonyl content (PCC) and thiobarbituric acid reactive substances (TBARS). People with bipolar disorder had higher PCC levels than healthy subjects. Those with major depression were not different from control subjects in either PCC or TBARS levels. Both bipolar disorder and major depression were associated with higher PCC levels in the a priori regression model controlling for possible confounders. These findings indicate that protein oxidative damage is present from early stages and can be seen as a sign of early illness activity in mood disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
16. Staging and neuroprogression in bipolar disorder: a systematic review of the literature.
- Author
-
Gama, Clarissa Severino, Kunz, Maurício, Magalhães, Pedro V. S., and Kapczinski, Flavio
- Subjects
- *
BIPOLAR disorder , *AFFECTIVE disorders , *BIOMARKERS ,PSYCHIATRIC research - Abstract
Introduction: The use of clinical staging models is emerging as a novel and useful paradigm for diagnosing severe mental disorders. The term "neuroprogression" has been used to define the pathological reorganization of the central nervous system along the course of severe mental disorders. In bipolar disorder (BD), neural substrate reactivity is changed by repeated mood episodes, promoting a brain rewiring that leads to an increased vulnerability to life stress. Method: A search in the PubMed database was performed with the following terms: "staging", "neuroprogression", "serum", "plasma", "blood", "neuroimaging", "PET scan", "fMRI", "neurotrophins", "inflammatory markers" and "oxidative stress markers", which were individually crossed with "cognition", "functionality", "response to treatments" and "bipolar disorder". The inclusion criteria comprised original papers in the English language. Abstracts from scientific meetings were not included. Results: We divided the results according to the available evidence of serum biomarkers as potential mediators of neuroprogression, with brain imaging, cognition, functioning and response to treatments considered as consequences. Conclusion: The challenge in BD treatment is translating the knowledge of neuronal plasticity and neurobiology into clinical practice. Neuroprogression and staging can have important clinical implications, given that early and late stages of the disorder appear to present different biological features and therefore may require different treatment strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
17. Exploring the Use of Lithium for Suicidality in Acute Settings: Rationale, Risks, and Uncertainties.
- Author
-
Amaral RR and Magalhães PVS
- Abstract
Competing Interests: No conflicts of interest declared concerning the publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
18. Socioeconomic and substance use changes in emerging adults and their relationship with mood disorders in a population-based cohort.
- Author
-
Farias CA, Cardoso TA, da Silva MM, D'Angelo F, Mondin TC, Souza LDM, da Silva RA, Kapczinski F, Jansen K, and Magalhães PVS
- Abstract
In this report, we aim to assess the interaction of bipolar disorder and major depressive disorder with the evolution of social roles, economic classification, and substance misuse in emerging adults. This is a longitudinal population-based study ( n = 231 at baseline), in which participants were reassessed at a mean of 5 years after baseline. A structured clinical interview was used to diagnose the participants with bipolar disorder and major depression; a control group without mood disorders was included. Men with mood disorders were less likely to be married in the beginning of the study and less likely to work in the follow-up. Women with major depression were less likely to study and more likely to be in a lower economic class at the beginning of the study. In comparison, women with bipolar disorder were less likely to live with their parents and more likely to live with their children in the first wave of the study. Substance misuse was more likely in people with mood disorders, especially in men, and women with bipolar disorder had the highest likelihood in the follow-up. Albeit longitudinal analyses were limited by a possibly insufficient sample size and mediating mechanisms for change, such as stigma, were not explored, the study suggests sex-related specificities regarding the change in social roles and substance use in people with mood disorders. Emerging adults, especially those with mood disorders, are in a period of change and instability and at a greater risk for substance use and abuse., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Farias, Cardoso, Silva, D’Angelo, Mondin, Souza, Silva, Kapczinski, Jansen and Magalhães.)
- Published
- 2022
- Full Text
- View/download PDF
19. Early illness progression in mood disorders: A population-based longitudinal study.
- Author
-
Farias CA, de Azevedo Cardoso T, Campos Mondin T, Dias de Mattos Souza L, Silva RAD, Kapczinski F, Jansen K, and Magalhães PVS
- Subjects
- Adolescent, Humans, Longitudinal Studies, Mood Disorders diagnosis, Bipolar Disorder diagnosis, Depressive Disorder, Major
- Abstract
This study is aimed at assessing changes in functioning among young people from the general population with bipolar disorder and major depressive disorder over a period of five years. Specifically, we hypothesized that significant illness progression would take place during euthymia over time in bipolar disorder. We conducted a longitudinal study with 231 people, assessed at baseline and again at a five-year follow-up. A structured clinical interview was used to diagnose participants with mood disorders. A control group without mood disorders was also included. Functioning was assessed with the Functioning Assessment Short Test, and linear mixed models were used to analyze the effect of psychopathology on change in functioning. Mood disorders were associated with significant functional impairment, but functioning significantly improved in both groups over the 5-year follow-up period. Depressive episodes, however, were associated with worse functioning at follow-up, independently of depression severity. In contrast to our initial hypothesis, we found a worsening of functioning in a five-year period associated only with depressive episodes. This suggests that interventions focused on the prevention of mood episodes early in the course of illness may be particularly promising to reduce adverse functioning outcomes., (Copyright © 2021 Elsevier B.V. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
20. Factors Associated With Seizure Adequacy Along the Course of Electroconvulsive Therapy.
- Author
-
Tedeschi EA, Patusco LM, Zahler S, Martini M, Chiavaro da Fonseca R, and Magalhães PVS
- Subjects
- Age Factors, Anticonvulsants administration & dosage, Brazil, Electroencephalography, Female, Humans, Male, Middle Aged, Quality of Health Care, Retrospective Studies, Thiopental administration & dosage, Time Factors, Electroconvulsive Therapy methods, Seizures etiology
- Abstract
Objectives: Eliciting a generalized seizure is essential to electroconvulsive therapy (ECT), but there is still a need to understand how patient and session variables interact to generate a seizure of adequate quality. Here, we investigate factors associated with motor seizure length as a measure of quality in a large database of patients who underwent ECT., Methods: This is a retrospective cohort including data from all adult inpatients who underwent ECT at a university hospital in Brazil from 2009 to 2015. We used linear mixed models to investigate the effects of patient, session, and medication on seizure length., Results: Session information was available for 387 patients, a total of 3544 sessions and 4167 individual stimulations. Multiple stimulations were necessary in 12.4% of sessions. Median seizure length was 30 seconds. Seizure length was directly correlated with stimulus dosage and inversely correlated with the session number, patient age, prescription of anticonvulsants in the day before and β-blockers during the session, and the thiopental dose. Use of benzodiazepines was not associated with a shorter seizure duration, irrespective of dose., Conclusions: We demonstrate here how motor seizure length evolves during a course of ECT. With a large number of sessions, we are able to integrate a host of factors in a prediction model. Seizure quality was influenced by a number of the studied factors, many of which are potentially modifiable and could be assessed before initiating and handled during treatment., Competing Interests: The authors have no conflicts of interest or financial disclosures to report., (Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
21. Functional impairment and cognitive performance in mood disorders: A community sample of young adults.
- Author
-
Reyes AN, Cardoso TA, Jansen K, Mondin TC, Souza LDM, Magalhães PVS, Kapczinski F, and Silva RA
- Subjects
- Adolescent, Adult, Brazil epidemiology, Cognition physiology, Cognition Disorders diagnosis, Cohort Studies, Cross-Sectional Studies, Female, Humans, Male, Mood Disorders diagnosis, Neuropsychological Tests, Young Adult, Cognition Disorders epidemiology, Cognition Disorders psychology, Mood Disorders epidemiology, Mood Disorders psychology, Residence Characteristics
- Abstract
The aim of this study was to compare the global functioning and cognitive performance in a community sample of young adults with mood disorders versus community controls. This was a cross-sectional study nested in a cohort study with a community sample. Data was collected from February 2012 to June 2014; specifically, at a mean of five years after the first phase, all young adults were invited to participate in a re-evaluation. Mini International Neuropsychiatric Interview - PLUS (MINI-PLUS) was used for the diagnosis of mood disorders. The Functional Assessment Short Test (FAST) and the Montreal Cognitive Assessment (MoCA) were used to assess the global functioning, and cognitive performance, respectively. Were included 1258 subjects. Functional impairment was greater in subjects with bipolar disorder when compared to community controls, and there were no differences between major depressive disorder and community controls. There were no significant differences in cognitive performance between young adults with mood disorders when compared to community controls. Functional impairment is a marker for bipolar disorder in young adults; however, gross cognitive impairment assessed by a screening test is not, possibly because cognition is impaired in more advanced stages of the disorder., (Copyright © 2017 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
22. Antioxidant treatments for schizophrenia.
- Author
-
Magalhães PV, Dean O, Andreazza AC, Berk M, and Kapczinski F
- Subjects
- Acetylcysteine therapeutic use, Allopurinol therapeutic use, Ascorbic Acid therapeutic use, Dehydroepiandrosterone therapeutic use, Drug Therapy, Combination methods, Ginkgo biloba, Humans, Randomized Controlled Trials as Topic, Schizophrenia metabolism, Selegiline therapeutic use, Vitamin E therapeutic use, Vitamins therapeutic use, Antioxidants therapeutic use, Antipsychotic Agents therapeutic use, Free Radical Scavengers therapeutic use, Oxidative Stress drug effects, Schizophrenia drug therapy
- Abstract
Background: There is accumulating evidence that progressive changes in brain structure and function take place as schizophrenia unfolds. Among many possible candidates, oxidative stress may be one of the mediators of neuroprogression, grey matter loss and subsequent cognitive and functional impairment. Antioxidants are exogenous or endogenous molecules that mitigate any form of oxidative stress or its consequences. They may act from directly scavenging free radicals to increasing anti-oxidative defences. There is evidence that current treatments impact oxidative pathways and may to some extent reverse pro-oxidative states in schizophrenia. The existing literature, however, indicates that these treatments do not fully restore the deficits in antioxidant levels or restore levels of oxidants in schizophrenia. As such, there has been interest in developing interventions aimed at restoring this oxidative balance beyond the benefits of antipsychotics in this direction. If antioxidants are to have a place in the treatment of this serious condition, the relevant and up-to-date information should be available to clinicians and investigators., Objectives: To evaluate the effect of antioxidants as add-on treatments to standard antipsychotic medication for improving acute psychotic episodes and core symptoms, and preventing relapse in people with schizophrenia., Search Methods: We searched the Cochrane Schizophrenia Group's Study-Based Register of Trials which is based on regular searches of CINAHL, BIOSIS, AMED, Embase, PubMed, MEDLINE, PsycINFO, and registries of clinical trials. There are no language, time, document type, or publication status limitations for inclusion of records in the register. We ran this search in November 2010, and again on 8 January 2015. We also inspected references of all identified studies for further trials and contacted authors of trials for additional information., Selection Criteria: We included reports if they were randomised controlled trials (RCTs) involving people with schizophrenia who had been allocated to either a substance with antioxidant potential or to a placebo as an adjunct to standard antipsychotic treatment., Data Collection and Analysis: We independently extracted data from these trials and we estimated risk ratios (RR) or mean differences (MD), with 95% confidence intervals (CI). We assessed risk of bias for included studies and created a 'Summary of findings' table using GRADE., Main Results: The review includes 22 RCTs of varying quality and sample size studying Ginkgo biloba, N-acetyl cysteine (NAC), allopurinol, dehydroepiandrosterone (DHEA), vitamin C, vitamin E or selegiline. Median follow-up was eight weeks. Only three studies including a minority of the participants reported our a priori selected primary outcome of clinically important response. Short-term data for this outcome (measured as at least 20% improvement in scores on Positive and Negative Syndrome Scale (PANSS)) were similar (3 RCTs, n = 229, RR 0.77, 95% CI 0.53 to 1.12, low quality evidence). Studies usually reported only endpoint psychopathology rating scale scores. Psychotic symptoms were lower in those using an adjunctive antioxidant according to the PANSS ( 7 RCTS, n = 584, MD -6.00, 95% CI -10.35 to -1.65, very low quality evidence) and the Brief Psychiatric Rating Scale (BPRS) (8 RCTS, n = 843, MD -3.20, 95% CI -5.63 to -0.78, low quality evidence). There was no overall short-term difference in leaving the study early (16 RCTs, n = 1584, RR 0.73, 95% CI 0.48 to 1.11, moderate quality evidence), or in general functioning (2 RCTs, n = 52, MD -1.11, 95% CI -8.07 to 5.86, low quality evidence). Adverse events were generally poorly reported. Three studies reported useable data for 'any serious adverse effect', results were equivocal (3 RCTs, n = 234, RR 0.65, 95% CI 0.19 to 2.27, low quality evidence). No evidence was available for relapse, quality of life or service use., Authors' Conclusions: Although 22 trials could be included in this review, the evidence provided is limited and mostly not relevant to clinicians or consumers. Overall, although there was low risk of attrition and selective data reporting bias within the trials, the trials themselves were not adequately powered and need more substantial follow-up periods. There is a need for larger trials with longer periods of follow-up to be conducted. Outcomes should be meaningful for those with schizophrenia, and include measures of improvement and relapse (not just rating scale scores), functioning and quality of life and acceptability and, importantly, safety data.
- Published
- 2016
- Full Text
- View/download PDF
23. Functioning in bipolar disorder with substance abuse/dependence in a community sample of young adults.
- Author
-
Cardoso Tde A, Mondin TC, Souza LD, da Silva RA, Magalhães PV, Kapczinski F, and Jansen K
- Subjects
- Adult, Brazil epidemiology, Comorbidity, Cross-Sectional Studies, Female, Health Status, Humans, Male, Prevalence, Social Behavior, Young Adult, Bipolar Disorder epidemiology, Bipolar Disorder psychology, Substance-Related Disorders epidemiology, Substance-Related Disorders psychology
- Abstract
Aim: To assess the functional impairment of young adults with bipolar disorder with substance abuse/dependence comorbidity., Method: Cross-sectional study within a community sample. Bipolar Disorder was assessed by qualified psychologists using The Mini International Neuropsychiatric Interview - PLUS (MINI-PLUS). Substance abuse and dependence was assessed using the "Alcohol, Smoking and Substance Involvement Screening Test" (ASSIST). Functional impairment was assessed using the Functional Assessment Short Test (FAST)., Results: The sample included 1259 young adults. The prevalence of Bipolar Disorder (BD) without Substance Abuse/Dependence (SAD) comorbidity was 5.9% (n=74), and the prevalence of bipolar disorder with substance abuse/dependence comorbidity was 1.4% (n=17). Both groups showed higher impairment in overall functioning, interpersonal relationship, and leisure time as compared to controls. In addition, BD+SAD showed higher impairment in the cognitive functioning domain of FAST., Limitation: A battery of neuropsychological tests was not performed., Conclusion: Functional impairment is associated with BD, independently of substance abuse or dependence. In addition, BD+SAD present a more severe impairment in the cognitive domain of FAST as compared to controls., (Copyright © 2015 Elsevier B.V. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
24. Clinical staging in bipolar disorder: focus on cognition and functioning.
- Author
-
Rosa AR, Magalhães PV, Czepielewski L, Sulzbach MV, Goi PD, Vieta E, Gama CS, and Kapczinski F
- Subjects
- Activities of Daily Living, Adult, Bipolar Disorder complications, Bipolar Disorder etiology, Bipolar Disorder physiopathology, Cognition Disorders physiopathology, Disease Progression, Female, Humans, Male, Middle Aged, Neuropsychological Tests, Psychiatric Status Rating Scales, Severity of Illness Index, Bipolar Disorder classification
- Abstract
Objective: Clinical staging has increasingly been considered suitable for psychiatric disorders such as bipolar disorder. A staging model of bipolar disorder could help clinicians understand the mechanisms underlying the course of the illness and guide prognosis and therapy. This study aimed to investigate differences in functional status and cognitive functioning in patients in different clinical stages of bipolar disorder., Method: Subjects who met DSM-IV criteria for bipolar disorder (n = 54) were recruited from the Bipolar Disorders Program at Hospital de Clínicas de Porto Alegre (Brazil) from October 2012 to October 2013. All patients had been in remission (score < 7 on the 17-item HDRS and the YMRS) for at least 1 month before assessment. They were classified into 4 clinical stages according to the model described by Kapczinski et al and compared to 43 healthy controls. Functional status was assessed by using the Functioning Assessment Short Test (FAST). Neuropsychological measures were performed to investigate cognitive functioning., Results: Significant differences in functional status were found between patients in all stages compared to controls (F = 33.014, P < .001), except for stage I (P = .104). Additionally, a very strong linear association was found between FAST scores and clinical stages, with FAST scores increasing from stage I to IV (F = 149.55, P < .001). In the bipolar group, stage I was associated with better occupational functioning than stage II (F = 48.344, P = .003). Stage IV patients experienced greater impairment in autonomy than stage III patients (F = 26.646, P = .004), and stage III patients experienced poorer autonomy than those in stage II (P = .004). With regard to cognitive measures, patients in late stages (stages III and IV) were more impaired than healthy controls (P < .001). A similar performance was found between patients in early stages (stages I and II) and healthy controls., Discussion: This study showed progressive functional changes from stage I to stage IV of bipolar disorder, with a greater impairment in patients in later stages of the illness. FAST scores seem to have a good discriminant ability to distinguish between patients in early versus late stages of bipolar disorder and could therefore contribute to the development of a bipolar disorder staging system., (© Copyright 2014 Physicians Postgraduate Press, Inc.)
- Published
- 2014
- Full Text
- View/download PDF
25. Neurotrophins, inflammation and oxidative stress as illness activity biomarkers in bipolar disorder.
- Author
-
Pfaffenseller B, Fries GR, Wollenhaupt-Aguiar B, Colpo GD, Stertz L, Panizzutti B, Magalhães PV, and Kapczinski F
- Subjects
- Biomarkers blood, Bipolar Disorder physiopathology, Bipolar Disorder therapy, Comorbidity, Humans, Inflammation genetics, Neuroglia metabolism, Bipolar Disorder metabolism, Inflammation metabolism, Nerve Growth Factors blood, Oxidative Stress physiology
- Abstract
Recent studies highlight the presence of systemic toxicity as an integral dimension of bipolar disorder pathophysiology, possibly linking this mood disorder with other medical conditions and comorbidities. This review summarizes recent findings on possible peripheral biomarkers of illness activity, with a focus on neurotrophins, inflammation and oxidative stress. The possible mechanisms underlying the systemic toxicity associated with acute episodes in bipolar disorder are also discussed. Finally, the authors outline novel therapies that emerge from this new research and the assessment of multiple biomarkers as a potential approach to improving management strategies in bipolar disorder.
- Published
- 2013
- Full Text
- View/download PDF
26. Is bipolar disorder an inflammatory condition? The relevance of microglial activation.
- Author
-
Stertz L, Magalhães PV, and Kapczinski F
- Subjects
- Allostasis physiology, Bipolar Disorder pathology, Cytokines physiology, Humans, Microglia immunology, Microglia pathology, Nervous System Diseases pathology, Bipolar Disorder physiopathology, Inflammation physiopathology, Microglia physiology, Nervous System Diseases physiopathology
- Abstract
Purpose of Review: Literature published over the past few years indicates that bipolar disorder has an inflammatory component but does not explicitly define bipolar disorder as an inflammatory or a noninflammatory condition., Recent Findings: Recent studies have shown that bipolar disorder involves microglial activation and alterations in peripheral cytokines and have pointed to the efficacy of adjunctive anti-inflammatory therapies in bipolar depression., Summary: The presence of active microglia and increased proinflammatory cytokines in bipolar disorder suggests an important role of inflammatory components in the pathophysiology of the disease, as well as a possible link between neuroinflammation and peripheral toxicity.
- Published
- 2013
- Full Text
- View/download PDF
27. Early functional impairment in bipolar youth: a nested population-based case-control study.
- Author
-
Jansen K, Magalhães PV, Tavares Pinheiro R, Kapczinski F, and Silva RA
- Subjects
- Adolescent, Adult, Bipolar Disorder diagnosis, Case-Control Studies, Comorbidity, Cross-Sectional Studies, Diagnostic and Statistical Manual of Mental Disorders, Early Diagnosis, Female, Humans, Male, Multivariate Analysis, Substance-Related Disorders epidemiology, Bipolar Disorder epidemiology, Bipolar Disorder physiopathology, Depressive Disorder, Major epidemiology, Depressive Disorder, Major physiopathology
- Abstract
Objectives: The objective of this report is to evaluate functioning in bipolar disorder in a population-based sample of young adults (18 to 24 years old). To this end, people with bipolar disorder were compared with matched participants with only depressive episodes and control subjects without a history of mood episodes., Methods: Case-control study nested in a population-based sample. Caseness was confirmed with the Structured Clinical Interview for DSM-IV. The Functioning Assessment Short Test was used as a measure of general functioning. A multivariate model was elaborated to account for potential confounders., Results: The sample consisted of 231 subjects. Both bipolar disorder (coef=0.60, SE=0.14, p<0.001) and major depression (coef=0.44, SE=0.14, p=0.001) were associated with functioning in the multivariate model. Current depressive symptoms appeared to influence functioning in those with major depression (Z=2.05, p=0.04), but not in those with bipolar disorder (Z=0.78, p=0.43)., Limitation: Neuropsychological testing was not performed and we see it as an important limitation of this study., Conclusion: This population-based study further reinforces the notion that functional impairment is a fundamental characteristic of bipolar illness. It is present from early stages and is not completely explained by mood symptoms., (Copyright © 2012 Elsevier B.V. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
28. Childhood trauma, impulsivity, and executive functioning in crack cocaine users.
- Author
-
Narvaez JC, Magalhães PV, Trindade EK, Vieira DC, Kauer-Sant'anna M, Gama CS, von Diemen L, Kapczinski NS, and Kapczinski F
- Subjects
- Adult, Analysis of Variance, Cross-Sectional Studies, Female, Humans, Linear Models, Male, Neuropsychological Tests, Principal Component Analysis, Psychological Tests, Adult Survivors of Child Abuse psychology, Cocaine-Related Disorders psychology, Crack Cocaine, Executive Function, Impulsive Behavior
- Abstract
Background: The use of crack cocaine is a major public health concern in Brazil and internationally. Recent data suggest that childhood trauma is associated with worse outcomes among cocaine users. This study had the objective of evaluating the relationship of childhood trauma with executive functioning and impulsivity in outpatients with crack cocaine use disorders., Methods: This is a cross-sectional study of 84 consecutive outpatients with a primary crack cocaine use disorder who sought treatment in Porto Alegre, Brazil. Childhood trauma was evaluated with the Childhood Trauma Questionnaire; executive functioning, with the Wisconsin Card Sorting Test; and impulsivity, with the Barratt Impulsivity Scale., Results: Childhood trauma was strongly associated with executive dysfunction and impulsivity, even when controlled for possible confounders., Conclusions: Childhood trauma may be associated with executive dysfunction and impulsivity in crack cocaine users. The full impact of trauma needs to be further investigated in longitudinal studies., (Copyright © 2012 Elsevier Inc. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
29. A bidimensional solution for outcomes in bipolar disorder.
- Author
-
Magalhães PV, Manzolli P, Walz JC, and Kapczinski F
- Subjects
- Adult, Bipolar Disorder diagnosis, Female, Humans, Male, Middle Aged, Treatment Outcome, Bipolar Disorder psychology, Bipolar Disorder therapy, Psychiatric Status Rating Scales
- Abstract
Although depressive symptoms have been consistently associated with lower quality of life and increased disability in bipolar disorder, their relation to manic symptoms is not as clear cut. A great overlap between these outcomes complicates the understanding of how they cluster together. We used exploratory factor analysis to clarify the relation between these constructs. We consecutively recruited 320 patients with bipolar disorder, and interviewers rated the Hamilton Depression and Anxiety Rating Scales, the Young Mania Rating Scale (YMRS), Clinical Global Impression (CGI), and the Global Assessment of Functioning (GAF). The self-rated Sheehan Disability Scale and the World Health Organization Quality of Life-BREF questionnaires were also collected. Two distinct and large dimensions emerged. Depression and anxiety, along with the self-rated scales, loaded in the first factor, whereas the YMRS, the GAF, and the CGI loaded in the second. These findings imply that evaluating self- and observer-rated outcomes may make up for a more thorough evaluation because each conveys unique illness information.
- Published
- 2012
- Full Text
- View/download PDF
30. Systemic toxicity in early-stage mood disorders.
- Author
-
Magalhães PV, Jansen K, Pinheiro RT, Klamt F, Teixeira AL, da Silva RA, and Kapczinski F
- Subjects
- Brain-Derived Neurotrophic Factor immunology, Humans, Nerve Growth Factors immunology, Time Factors, Inflammation immunology, Mood Disorders immunology, Oxidative Stress immunology
- Published
- 2011
- Full Text
- View/download PDF
31. Correlates and impact of obsessive-compulsive comorbidity in bipolar disorder.
- Author
-
Magalhães PV, Kapczinski NS, and Kapczinski F
- Subjects
- Adult, Age of Onset, Bipolar Disorder psychology, Chi-Square Distribution, Comorbidity, Cross-Sectional Studies, Diagnostic and Statistical Manual of Mental Disorders, Female, Humans, Male, Middle Aged, Obsessive-Compulsive Disorder psychology, Prevalence, Quality of Life psychology, Bipolar Disorder epidemiology, Obsessive-Compulsive Disorder epidemiology
- Abstract
Background: Anxiety morbidity in general is frequent and harmful in bipolar disorder. Little is known, however, whether obsessive-compulsive comorbidity entails particular effects. This report aims to evaluate the prevalence and impact of obsessive-compulsive disorder (OCD) comorbidity in a relatively large clinical sample of bipolar disorder, with other lifetime anxiety comorbidities used as a more rigorous control group., Methods: A cross-sectional study in a consecutive clinical sample, with anxiety comorbidity derived from the intake Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, was conducted. Anxiety was assessed with the Hamilton Anxiety Rating Scale. The Young Mania Rating Scale and the Hamilton Depression Rating Scale were used to assess (hypo)manic and depressive symptoms. The domains of the WHOQOL BREF were used to evaluate quality of life., Results: Lifetime prevalence of OCD comorbidity was 12.4%. No cases of OCD were detected during mania. Compared with subjects with no anxiety comorbidity, those with lifetime OCD were more likely to have a history of suicide attempts, rapid cycling, and alcohol dependence. Patients with OCD had a lower score on all domains of the WHOQOL. Compared with those with other lifetime anxiety disorders, those with OCD had more anxiety, which mediated a lower WHOQOL social domain., Conclusions: Bipolar disorder patients with obsessive-compulsive comorbidity have a number of indicators of an overall more severe illness. The presence of more anxiety symptoms and a lower social quality of life may be more specific features of the bipolar-OCD comorbidity., (Copyright 2010 Elsevier Inc. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
32. Functional impact of biological rhythm disturbance in bipolar disorder.
- Author
-
Giglio LM, Magalhães PV, Kapczinski NS, Walz JC, and Kapczinski F
- Subjects
- Adult, Female, Humans, Interview, Psychological methods, Linear Models, Male, Middle Aged, Neuropsychological Tests, Psychiatric Status Rating Scales, Sleep Disorders, Circadian Rhythm etiology, Bipolar Disorder complications, Chronobiology Disorders etiology, Cognition Disorders etiology, Executive Function physiology
- Abstract
Bipolar disorder (BD) is characterized by frequent recurrence, incomplete recovery, cognitive dysfunction and poor functioning. Impairment lingers in the interepisodic period and mechanisms leading to this dysfunctional state are not fully comprehended. To our knowledge the association of biological rhythm dysfunction with functioning in BD has not been assessed directly. The objective of this study was to measure and quantify the impact of rhythm dysfunction on interepisodic functioning in BD. We also tested the association between executive functioning and sleep and rhythm problems. Eighty-one outpatients with BD and 79 matched control subjects were consecutively recruited. Functional impairment was assessed with the Functioning Assessment Short Test (FAST) and biological rhythms with the Biological Rhythms Interview of Assessment in Neuropsychiatry (BRIAN). A subsample had their executive functioning assessed with the Wisconsin Card Sorting Test (WCST). Patients and control subjects were well matched. Functioning and rhythm scores were correlated in patients and control subjects. The BRIAN score was the strongest predictor of functioning in the regression model. Biological rhythms partially mediated the impairment associated with bipolar disorder. The rhythm score was also associated with executive functioning. Biological rhythm dysfunction was a potent predictor of functioning in interepisodic patients with bipolar disorder; it may also mediate much of the disorder-induced disability. These results further the notion that biological rhythms may be interesting targets for diverse interventions aiming to improve functioning and prevent relapse in interepisodic bipolar disorder., (Copyright 2009 Elsevier Ltd. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.